Pharma Archives - Page 62 of 80 - Life Sciences Times

Vertex Teams Up with Jayson Tatum to Highlight JOURNAVX, a Non-Opioid Pain Medicine

September 23, 2025

Meet the Man Behind FDA-Approved Bladder Cancer Breakthrough: Dr. Purnanand Sarma and the Journey of INLEXZO™

September 22, 2025

Blue Cross Blue Shield of Massachusetts Appoints Sophie Clarke as Chief Strategy Officer

September 19, 2025

THIS WEEK'S STORIES

Sunflower Therapeutics Reaches First Milestone in HPV Vaccine Collaboration with SK bioscience

September 18, 2025

Areteia Therapeutics Reports Positive Phase III Results for Oral Dexpramipexole in Eosinophilic Asthma

September 16, 2025

Colossal Advances Dodo De-Extinction with Breakthrough in Pigeon Germ Cell Science and Secures $120 Million in New Funding

September 17, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Pharma

FDA Issues Complete Response Letter for Scholar Rock’s Apitegromab, Citing Catalent Facility Observations

Vertex Teams Up with Jayson Tatum to Highlight JOURNAVX, a Non-Opioid Pain Medicine

KalVista Wins EU, Swiss Approvals for EKTERLY, First Oral On-Demand Therapy for Hereditary Angioedema

Nuvation Bio Gains Japan Approval for IBTROZI in Advanced ROS1-Positive Lung Cancer

Deciphera Wins European Commission Approval for ROMVIMZA in Treating Tenosynovial Giant Cell Tumor

Most Read

FDA Issues Complete Response Letter for Scholar Rock’s Apitegromab, Citing Catalent Facility Observations

Survey Finds Real-Time CPR Coaching Boosts Confidence in Cardiac Emergencies

Vertex Teams Up with Jayson Tatum to Highlight JOURNAVX, a Non-Opioid Pain Medicine

Community Health Options Taps Gradient AI to Enhance Group Health Underwriting and Renewals

EDITOR PICKS

Vertex Teams Up with Jayson Tatum to Highlight JOURNAVX, a Non-Opioid Pain Medicine

Meet the Man Behind FDA-Approved Bladder Cancer Breakthrough: Dr. Purnanand Sarma and the Journey of INLEXZO™

Blue Cross Blue Shield of Massachusetts Appoints Sophie Clarke as Chief Strategy Officer

THIS WEEK'S STORIES

Sunflower Therapeutics Reaches First Milestone in HPV Vaccine Collaboration with SK bioscience

Areteia Therapeutics Reports Positive Phase III Results for Oral Dexpramipexole in Eosinophilic Asthma

Colossal Advances Dodo De-Extinction with Breakthrough in Pigeon Germ Cell Science and Secures $120 Million in New Funding

POPULAR CATEGORY

ABOUT US

FOLLOW US